: Overview of the analysis. The study presented here consists of three parts: 1) Preprocessing, annotation and exploration of the data. 2) Building classification models to predict carcinogenicity in rats, which includes the investigation of the effects of dose-, time-, and tissue-specificity, effects of sample size, and others. 3) Biology of exposure, where we defined carcinogenicity signatures, investigated enriched pathways and derived putative modes of action.
corresponding to a specificity of ~99.3%, this would translate into a sensitivity of ~20.9%, and lead to the detection of 1756 out of the expected 8400 true carcinogens. Conversely, adopting a 1:2 FP/FN cost function would lead to an increased sensitivity of 88.4% and a drop in specificity to 36.3%. These scenarios are presented to show the considerable flexibility afforded by the classifier, and to emphasize that the appropriate specificity/sensitivity trade-off will be determined by the main purpose for which the classifier is used. If its primary purpose is to prioritize compounds for further screening, a high sensitivity (few FNs) would be preferable, even at the cost of a lower specificity (more FPs). On the other hand, if its purpose is to prove conclusively that a compound is carcinogenic (e.g., for regulatory purposes), then increasing the specificity even at the cost of a lower sensitivity might be preferable.
Structural features as predictors. Evaluation of the relative predictive power of gene expression and chemicals' structural features conclusively shows the higher information content of the former over the latter, but also shows that augmenting the prediction models with such structural information marginally improves classification, in particular genotoxicity. The top structural features as ranked by the Random Forest variable importance include chloride.p.alkyl, halde..p.alkyl, nitrosamine, nitrose and benzene.1.alkyl.4.carbonyl, among others, which enable compound-DNA interaction and consequently are predictive of genotoxicity. Since the 3D structural features are easily accessible for most compounds, it seems sensible to incorporate these in any future classifier.
Material
For the Gene set enrichment analysis as well as the projection into pathway space we used the gene sets of the canonical pathways in the second compendium of the molecular signature database (MSigDB) [40] version 3.0, which includes 880 gene sets. All gene sets were mapped from human gene symbols to rat Ensembl gene identifiers using the R/Bioconductor package BiomaRt.
For the DrugMatrix, each compound is annotated with 1,902 dichotomous chemical structure descriptors extracted from the Leadscope Enterprise 3.0 software package (Columbus, Ohio). All samples were profiled on the Affymetrix Rat 230.2 microarray.
Methods
Exploratory analysis -In order to reduce the dimension of the dataset and have a 2 or 3-dimensional representation of the dataset we used Principal Component Analysis (PCA) using the R package prcomp and Multidimensional Scaling (MDS) using the R package ggplot2.
Defining the Perturbational Transcriptome
The list of genes that significantly respond to chemical perturbation was identified by carrying out a two-group moderated t-test between the control samples and the corresponding treatment samples for each compound (at a given dose) separately, while correcting for the confounding effect of time. Only the genes with FDR-corrected q-value≤0.01 and fold-change≥1.5 (in either direction) in at least five compounds were included. A gene-by-compound matrix was then constructed, with each column representing the vector of "control vs. treatment" t-scores for the corresponding compound. A total of 191 compound-dose instances, corresponding to 138 distinct compounds for which either carcinogenicity or genotoxicity information was available, were included in this analysis. Hierarchical clustering of both the compounds and the genes based on the t-scores' matrix was performed, and the results visualized in a heatmap with the color-coding based on the t-test's q-values and the direction of the up-regulation ( Figure  2a) . The procedure yielded a clear two-cluster stratification, with one of the clusters highly enriched for carcinogenic compounds. Association between cluster membership and carcinogenicity (genotoxicity) status of the compounds was assessed by Fisher test.
Each gene was tested for its association with carcinogenicity, by performing a Fisher test between the gene status (0: not differentially expressed; 1: differentially expressed) and the compound status (+: carcinogenic; -: non-carcinogenic) across compounds, and the nominal p-values were corrected for multiple hypothesis testing by the FDR procedure (Figure 2b , columns grouped under 'Enrichment').
To test whether the number of genes up-/down-regulated by each compound was significantly higher in carcinogens than in non-carginogens, a Kolmogorov-Smirnoff test was performed as shown in Figure S2 . The test evaluates whether the distribution of carcinogenic compounds is significantly skewed toward either ends of the list of compounds sorted according to the number of genes they up-/down-regulate. The results show a significant over-representation of carcinogenic compounds toward the high-end of the sorted list. Figure S2 : Distribution of number of up-/down-regulated genes across compounds. The carcinogenic compounds (red ticks) are significantly skewed toward the right-end of the distribution, as measured by a KS test (bottom).
Tissue-agnostic carcinogenicity classifiers We first assessed whether it is possible to predict the carcinogenicity of a compound independent of the tumor site. To this end, Random Forest classifiers were built from the DrugMatrix liver samples using tissue agnostic carcinogenicity labels, whereby a compound is labeled as carcinogenic if it is found to induce cancer in any tissue type at any dose. The random resampling-based estimation of classification performance yielded an AUC of 64.8% when predicting carcinogenicity in this fashion (Table S1 and corresponding ROC curves in Figure S3 ). Figure For Figure 6b we used the top 50 pathways as ranked their variable importance for classifying the carcinogenic potential of a chemical compound. The pathways as well as the chemical compound were grouped using hierarchical clustering. In order to acquire the driving genes for each cluster or mode of action we clustered the chemical compounds only in the space of the pathways of a given mode of action. We then split these hierarchical clusters in two groups at the top node of the dendrogram and went back to the actual gene expression data for these two groups, where we performed differential gene expression analysis (limma) between those groups in order to get a gene ranking. We then reduced the list of genes to those that are present in any of the pathways that defined a given mode of action and reported the top ranking genes ( Figure 6c -right column).
Mode of Action
Figure S3 -Tissue-agnostic carcinogenicity prediction ROC curves corresponding to random forest classifiers trained on liver samples but using tissue-agnostic carcinogenicity labels. The red curves show the means over 200 iterations of a 70%/30% train/test dataset split, whereas the dashed curves indicate the first and third quartiles respectively. Figure S8 -Effect of dose dependence on prediction ROC curves corresponding to random forest classifiers trained on a) dose-specific carcinogenicity labels; and b) dose-independent carcinogenicity labels. For the doseindependent labels we used the annotation at the maximum dose and used it for all other doses. The red curves show the means over 200 iterations of a 70%/30% train/test dataset split, whereas the dashed curves indicate the first and third quartiles respectively.
Figure S9 -Random resampling scheme -Chemical compounds are split into a 70% training set and a 30% test set (stratified with respect to the phenotype to be predicted). The gene expression profiles associated with the training set are then used to train a classification model, which is used to predict the class labels of the test set. The predicted class labels are then compared with the actual labels and the prediction performance (AUC) can be evaluated. To achieve a robust evaluation and get an estimate of the standard error the random 70%/30% split is repeated 200 times.
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